PC World - Oracle on Friday announced plans to buy Phase Forward, which develops software for drug manufacturers, for about US $685 million. The deal is expected to close mid-year.
Software News
PC World - Oracle on Friday announced plans to buy Phase Forward, which develops software for drug manufacturers, for about US $685 million. The deal is expected to close mid-year.
Software News